In contrast, among specific types of PCa, such as pancreatic neuroendocrine tumors, only 20% of the patients were positive for claudin-18.2, with a strong staining intensity in all the positive patients (20). This evidence concerns the gene CLDN18 and pancreatic neuroendocrine tumor.